Catalyst Wire Dossier Catalyst Wire Dossier

ASC30 injection

ASC30 · Ascletis Pharma (China) Co., Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASC30 injection, covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With Obesity [Phase 1, Phase 2]

See pricing